Overview

Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients

Status:
Completed
Trial end date:
2017-03-16
Target enrollment:
Participant gender:
Summary
Atopic Dermatitis is a chronic relapsing eczematous skin disease with increasing prevalence. Complementary and alternative medical approaches have been employed to relieve symptoms of Atopic Dermatitis. We aim to establish basic clinical efficacy and safety data for Jaungo in patients with Atopic Dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Kyung Hee University Hospital at Gangdong